Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Pharmacol
2018 Feb 01;932:90-100. doi: 10.1124/mol.117.110569.
Show Gene links
Show Anatomy links
GABA Type A Receptor Activation in the Allosteric Coagonist Model Framework: Relationship between EC50 and Basal Activity.
Akk G
,
Shin DJ
,
Germann AL
,
Steinbach JH
.
???displayArticle.abstract???
The concerted transition model for multimeric proteins is a simple formulation for analyzing the behavior of transmitter-gated ion channels. We used the model to examine the relationship between the EC50 for activation of the GABA type A (GABAA) receptor by the transmitter GABA and basal activity employing concatemeric ternary GABAA receptors expressed in Xenopus oocytes. Basal activity, reflecting the receptor function in the absence of the transmitter, can be changed either by mutation to increase constitutive activity or by the addition of a second agonist (acting at a different site) to increase background activity. The model predicts that either mechanism for producing a change in basal activity will result in identical effects on the EC50 We examined receptor activation by GABA while changing the level of basal activity with the allosterically acting anesthetics propofol, pentobarbital, or alfaxalone. We found that the relationship between EC50 and basal activity was well described by the concerted transition model. Changes in the basal activity by gain-of-function mutations also resulted in predictable changes in the EC50 Finally, we altered the number of GABA-binding sites by a mutation and again found that the relationship could be well described by the model. Overall, the results support the idea that interactions between the transmitter GABA and the allosteric agonists propofol, pentobarbital, or alfaxalone can be understood as reflecting additive and independent free energy changes, without assuming any specific interactions.
Akk,
Pregnenolone sulfate block of GABA(A) receptors: mechanism and involvement of a residue in the M2 region of the alpha subunit.
2001, Pubmed
Akk,
Pregnenolone sulfate block of GABA(A) receptors: mechanism and involvement of a residue in the M2 region of the alpha subunit.
2001,
Pubmed
Akk,
Activation and modulation of concatemeric GABA-A receptors expressed in human embryonic kidney cells.
2009,
Pubmed
Amin,
GABAA receptor needs two homologous domains of the beta-subunit for activation by GABA but not by pentobarbital.
1993,
Pubmed
,
Xenbase
Auerbach,
Thinking in cycles: MWC is a good model for acetylcholine receptor-channels.
2012,
Pubmed
Baumann,
Forced subunit assembly in alpha1beta2gamma2 GABAA receptors. Insight into the absolute arrangement.
2002,
Pubmed
,
Xenbase
Baumann,
Individual properties of the two functional agonist sites in GABA(A) receptors.
2003,
Pubmed
,
Xenbase
Bianchi,
Slow phases of GABA(A) receptor desensitization: structural determinants and possible relevance for synaptic function.
2002,
Pubmed
Bracamontes,
Occupation of either site for the neurosteroid allopregnanolone potentiates the opening of the GABAA receptor induced from either transmitter binding site.
2011,
Pubmed
,
Xenbase
Bracamontes,
Steroid interaction with a single potentiating site is sufficient to modulate GABA-A receptor function.
2009,
Pubmed
,
Xenbase
Burzomato,
Single-channel behavior of heteromeric alpha1beta glycine receptors: an attempt to detect a conformational change before the channel opens.
2004,
Pubmed
Campo-Soria,
Mechanism of action of benzodiazepines on GABAA receptors.
2006,
Pubmed
,
Xenbase
Chang,
Allosteric activation mechanism of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine.
1999,
Pubmed
,
Xenbase
Chang,
Stoichiometry of a recombinant GABAA receptor.
1996,
Pubmed
,
Xenbase
Changeux,
Allosteric receptors after 30 years.
1998,
Pubmed
DEL CASTILLO,
Interaction at end-plate receptors between different choline derivatives.
1957,
Pubmed
Eaton,
Multiple Non-Equivalent Interfaces Mediate Direct Activation of GABAA Receptors by Propofol.
2016,
Pubmed
Edelstein,
Allosteric proteins after thirty years: the binding and state functions of the neuronal alpha 7 nicotinic acetylcholine receptors.
1996,
Pubmed
Forman,
Monod-Wyman-Changeux allosteric mechanisms of action and the pharmacology of etomidate.
2012,
Pubmed
Forman,
Mutations in the GABAA receptor that mimic the allosteric ligand etomidate.
2012,
Pubmed
,
Xenbase
Germann,
Activation and modulation of recombinant glycine and GABAA receptors by 4-halogenated analogues of propofol.
2016,
Pubmed
,
Xenbase
Gielen,
Benzodiazepines modulate GABAA receptors by regulating the preactivation step after GABA binding.
2012,
Pubmed
,
Xenbase
Goldschen-Ohm,
A nonequilibrium binary elements-based kinetic model for benzodiazepine regulation of GABAA receptors.
2014,
Pubmed
Gupta,
A mechanism for acetylcholine receptor gating based on structure, coupling, phi, and flip.
2017,
Pubmed
Haas,
GABAA receptor subunit gamma2 and delta subtypes confer unique kinetic properties on recombinant GABAA receptor currents in mouse fibroblasts.
1999,
Pubmed
Hernandez,
Altered Channel Conductance States and Gating of GABAA Receptors by a Pore Mutation Linked to Dravet Syndrome.
2017,
Pubmed
Jackson,
Perfection of a synaptic receptor: kinetics and energetics of the acetylcholine receptor.
1989,
Pubmed
Jackson,
Kinetics of unliganded acetylcholine receptor channel gating.
1986,
Pubmed
Jayakar,
Multiple propofol-binding sites in a γ-aminobutyric acid type A receptor (GABAAR) identified using a photoreactive propofol analog.
2014,
Pubmed
Jones,
Desensitized states prolong GABAA channel responses to brief agonist pulses.
1995,
Pubmed
KATZ,
A study of the desensitization produced by acetylcholine at the motor end-plate.
1957,
Pubmed
Karlin,
On the application of "a plausible model" of allosteric proteins to the receptor for acetylcholine.
1967,
Pubmed
Koshland,
Comparison of experimental binding data and theoretical models in proteins containing subunits.
1966,
Pubmed
Lape,
On the nature of partial agonism in the nicotinic receptor superfamily.
2008,
Pubmed
Lema,
Modes and models of GABA(A) receptor gating.
2006,
Pubmed
MONOD,
ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.
1965,
Pubmed
Mukhtasimova,
Improved resolution of single channel dwell times reveals mechanisms of binding, priming, and gating in muscle AChR.
2016,
Pubmed
Plested,
Single-channel study of the spasmodic mutation alpha1A52S in recombinant rat glycine receptors.
2007,
Pubmed
Ruesch,
An allosteric coagonist model for propofol effects on α1β2γ2L γ-aminobutyric acid type A receptors.
2012,
Pubmed
,
Xenbase
Rüsch,
Gating allosterism at a single class of etomidate sites on alpha1beta2gamma2L GABA A receptors accounts for both direct activation and agonist modulation.
2004,
Pubmed
,
Xenbase
Rüsch,
Classic benzodiazepines modulate the open-close equilibrium in alpha1beta2gamma2L gamma-aminobutyric acid type A receptors.
2005,
Pubmed
,
Xenbase
Steinbach,
Modulation of GABA(A) receptor channel gating by pentobarbital.
2001,
Pubmed
Ziemba,
Correction for Inhibition Leads to an Allosteric Co-Agonist Model for Pentobarbital Modulation and Activation of α1β3γ2L GABAA Receptors.
2016,
Pubmed
,
Xenbase
